Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Hyaluronan Fragment by Nakhia Impex for Cancer Pain: Likelihood of Approval
Hyaluronan Fragment is under clinical development by Nakhia Impex and currently in Phase II for Cancer Pain. According to GlobalData,...
Hyaluronan Fragment by Nakhia Impex for Wounds: Likelihood of Approval
Hyaluronan Fragment is under clinical development by Nakhia Impex and currently in Phase II for Wounds. According to GlobalData, Phase...
Hyaluronan Fragment by Nakhia Impex for Chronic Skin Inflammation: Likelihood of Approval
Hyaluronan Fragment is under clinical development by Nakhia Impex and currently in Phase II for Chronic Skin Inflammation. According to...